FDA-cleared M. genitalium product
July 2018—SpeeDx’s ResistancePlus MG Positive Control kit has been cleared by the FDA.
Webinars and Sponsored Roundtables — Register Now
Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology,
Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
Blood collection tubes for cfDNA, CTCs
July 2018—Biocept has launched its CEE-Sure blood collection tubes for research use only, and internationally distributed through VWR. CEE-Sure BCTs allow for the intact transport of liquid biopsy samples at room temperature.
Echo Lumena gets FDA clearance
July 2018—Immucor announced its next-generation, fully automated Echo Lumena received FDA clearance. Echo Lumena is the company’s fifth-generation benchtop immunohematology instrument, designed for small- to mid-volume laboratories.
High-def PCR respiratory assay
July 2018—ChromaCode announced the publication of studies from Dartmouth-Hitchcock Medical Center and USC’s Keck School of Medicine highlighting the utility of the company’s HDPCR chemistry and the performance of the HDPCR respiratory assay, for research use only.
BD unveils informatics, automation solutions at ECCMID
July 2018—Becton Dickinson introduced several informatics and automation solutions for clinical laboratories at the European Congress of Clinical Microbiology and Infectious Diseases in Madrid, in April.
First Atellica Solution with Aptio installed in U.S.
July 2018—Siemens Healthineers completed the first U.S. installation of its Atellica Solution immunoassay and clinical chemistry analyzers connected to Aptio Automation at Access Medical Laboratories in Jupiter, Fla.
FDA oncology approvals
July 2018—FDA granted in June accelerated approval to pembrolizumab (Keytruda, Merck) for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma or for patients who have relapsed after two or more prior lines of therapy.
Expanded use of Validate Fibrinogen kit
July 2018—LGC Maine Standards announced that its Validate Fibrinogen for linearity and calibration verification is available on Instrumentation Laboratory’s ACL Top 500, Siemens Healthineers’ Sysmex CS-2500, and Diagnostica Stago’s STA-R Evolution hemostasis test systems.
Streck launches sed-rate analyzer
July 2018—Streck and Diesse Diagnostica Senese have introduced the Cube 30 Touch, an automated instrument for high-volume erythrocyte sedimentation rate testing in EDTA tubes.
Qiagen launches QIAstat-Dx in Europe
July 2018—Qiagen announced the European launch of its QIAstat-Dx, a next-generation multiplex molecular diagnostic that provides a one-step, fully integrated molecular analysis of common syndromes as tested for in syndromes in infections, oncology, and other diseases.